Skip to main content
Watch Insiders

Corporate insider profile

David Malcom Rodman Insider Trades

Latest reported as Chief Medical Officer of Mineralys Therapeutics, Inc. (MLYS).

Purchase filings
0
Reported companies
1
Net open-market value
-$2,474,346.50
Latest transaction
Aug 10, 2026

Affiliated corporations

Reported company relationships

MLYSLatest reported

Mineralys Therapeutics, Inc.

Chief Medical Officer

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Aug 10, 2026Mineralys Therapeutics, Inc. (MLYS)Chief Medical OfficerSale2,170$27.09$58,785
Jul 17, 2026Mineralys Therapeutics, Inc. (MLYS)Chief Medical OfficerSale416$26.53$11,036
Jul 15, 2026Mineralys Therapeutics, Inc. (MLYS)Chief Medical OfficerSale20,407$27.28$556,672
Jul 9, 2026Mineralys Therapeutics, Inc. (MLYS)Chief Medical OfficerSale2,171$30.30$65,781
Jun 17, 2026Mineralys Therapeutics, Inc. (MLYS)Chief Medical OfficerSale14,474$24.19$350,087
Jun 12, 2026Mineralys Therapeutics, Inc. (MLYS)Chief Medical OfficerSale8,519$24.20$206,151
May 18, 2026Mineralys Therapeutics, Inc. (MLYS)Chief Medical OfficerSale417$27.55$11,488
May 13, 2026Mineralys Therapeutics, Inc. (MLYS)Chief Medical OfficerSale22,575$28.91$652,639
Apr 17, 2026Mineralys Therapeutics, Inc. (MLYS)Chief Medical OfficerSale416$31.33$13,033
Apr 15, 2026Mineralys Therapeutics, Inc. (MLYS)Chief Medical OfficerSale20,406$26.89$548,672